Poland – Pharmaceutical products – Successive deliveries of medicines for the Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch – task No. 5: Tisagenlecleucel

Opportunity description

1. Successive deliveries of medicines for the Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch – task No. 5: Tisagenlecleucel 2. Procurement procedure: negotiated procedure without prior publication Legal basis: Article 214(1)(6) of the Public Procurement Law. 3. Planned performance period: successively for a period of 24 months from the date of conclusion of the contract or until the earlier exhaustion of the Contracting Authority’s financial limit for the performance of the contract specified in § 3(1) of the contract. The contract shall expire upon exhaustion of the nominal contract amount or the end of the period for which it was concluded, whichever of these circumstances occurs first. 4. The Contracting Authority invited the following Contractor to negotiations: "NOVARTIS POLAND" LIMITED LIABILITY COMPANY ul. MARYNARSKA, No. 15, 02-674 Warsaw jaroslaw.nieradko@novartis.com Successive deliveries of medicines for the Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch – task No. 5: Tisagenlecleucel Procedure: neg-wo-call. Review the original TED notice for the complete requirement, lots, amendments and attachments.